Use of step therapy protocols prohibition for the treatment of neurological conditions

This Minnesota bill prohibits health insurance plans from using step therapy protocols to limit coverage for FDA-approved drugs treating neurological conditions. It directly affects people with neurological disorders and the health plans that cover them by requiring insurers to pay for these medications if they are on the plan's formulary and align with official medical guidelines. The law defines neurological conditions as any disorder causing neurological impairment and specifies that coverage cannot be denied based on step therapy if the drug is approved for the patient's specific condition and supported by clinical practice guidelines. The policy change will take effect on January 1, 2027, applying to any health plans offered, issued, or renewed on or after that date.